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Purpose: The aim of the study was to investigate the association of polymorphisms of the interleukin-23 receptor
(IL23R) gene with Fuchs’ syndrome in a Chinese Han population.
Methods: Three single-nucleotide polymorphisms (SNPs), rs7517847, rs11209032 and rs17375018 of IL23R were
genotyped in 138 Chinese Han patients with Fuchs’ syndrome and 407 healthy controls by using the polymerase chain
reaction-restriction fragment length polymorphism (PCR-RFLP) method. Data were analyzed by χ2 analysis.
Results: All genotype and allele distributions in patients with Fuchs’ syndrome and healthy controls were in Hardy–
Weinberg equilibrium. The frequency of the rs11209032 AA genotype was significantly increased in patients with Fuchs’
syndrome as compared to controls (corrected p [pc]=0.036, OR 1.86, 95%CI 1.21 to 2.86). There were no statistically
significant differences between patients and healthy controls concerning the other two tested SNPs (rs17375018 and
rs7517847). The haplotypes of the tested SNPs were not different between patients and controls. Additionally, analysis
according to gender did not show any influence of sex on the association of IL23R with Fuchs’ syndrome.
Conclusions: Our results suggested that the rs11209032 AA genotype of the IL23R gene may predispose for Fuchs’
syndrome in Chinese patients.
Fuchs’ syndrome is a chronic inflammatory eye disease,
which usually presents as unilateral anterior uveitis in young
adults [1]. In Chinese patients it is characterized by a mild
uveitis  with  characteristic  keratic  precipitates,  varying
degrees of iris depigmentation and occasional heterochromia
[2]. Although the etiology of Fuchs’ syndrome is not fully
understood, several studies have revealed that genetic factors
may be involved in the pathogenesis of the disease [3]. Makley
et al. [4] described that monozygotic twins both developed
Fuchs’  syndrome.  Earlier  studies  have  shown  that  the
frequency of human leukocyte antigen-CW3 (HLA-CW3) and
human  leukocyte  antigen-DRW53  (HLA-DRW53)  was
decreased in patients with Fuchs’ syndrome as compared with
healthy  controls  [3].  Additionally,  polymorphisms  of  the
cytotoxic T cell antigen (CTLA) 4 gene have been found to be
associated with Fuchs’ syndrome [5].
The interleukin-23 receptor (IL23R) gene is located on
chromosome 1p31 and the encoded protein forms a receptor
for IL23. IL23R is highly expressed in dendritic cells (DC)
and has recently been recently identified to be involved in
several  chronic  inflammatory  diseases  [6-10].  A  genome-
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wide association study has revealed that polymorphisms of
the  IL23R  gene  are  associated  with  inflammatory  bowel
disease (IBD) [8]. Several SNPs in IL23R have been found to
be associated with chronic inflammatory diseases including
IBD, psoriasis, and multiple sclerosis [11-13]. Recent studies
from our group have shown that IL23R gene polymorphisms
are associated with Behcet’s disease, an important uveitis
entity in China [10]. However, it is not clear whether IL23R
gene polymorphisms are associated with Fuchs’ syndrome, a
disorder possibly mediated by an immune response to a viral
(Rubella) infection. In this study we examined the association
of IL23R polymorphisms with Fuchs’ syndrome and showed
an increased frequency of the AA genotype of rs11209032 in
these patients.
METHODS
Patients and healthy controls: A total of 138 patients with
Fuchs syndrome and 407 age-, sex-, ethnic-matched healthy
controls were recruited from the First Affiliated Hospital of
Chongqing Medical University (Chongqing, P.R. China) or
the  Uveitis  Study  Center  of  the  Sun  Yat-sen  University
(Guangzhou, P.R. China). The diagnosis of Fuchs’ syndrome
was principally a clinical one and generally based on the
classic description by Kimura et al. [14] in 1955 adjusted for
the  typical  presentation  in  Chinese  patients  [2].  Age  and
gender  distribution  are  shown  in  Table  1.  The  study  was
approved by the local institutional ethnics committee of The
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2585First Affiliated Hospital of Chongqing Medical University.
All  procedures  followed  the  tenets  of  the  Declaration  of
Helsinki. The written informed consent was obtained from all
the subjects.
Genomic DNA extraction and genotyping:  Blood samples
were collected in EDTA tubes and kept at −70 °C until use.
Genomic DNA was extracted by the QIAamp DNA Blood
Mini Kit (Qiagen, Hilden, Germany). Amplification of the
target DNA in the IL23R gene was analyzed by the polymerase
chain reaction (PCR) using primers presented in Table 2. Each
PCR reaction was performed in 10 μl containing 5 μl Premix
Taq  (Ex  Taq  Version;  TaKaRa  Biotechnology  Co.  Ltd.,
Dalian, China), 20 pmoles primers and 0.2 μg of genomic
DNA.  The  PCR  conditions  were  as  follows:  initial
denaturation at 95 °C for 5 min followed by 38 cycles of
denaturation  at  94  °C  for  30  s,  annealing  at  different
temperatures (61 °C for rs11209032, 55 °C for rs17375018,
and 58 °C for rs7517847) for 30 s, extension at 72 °C for 30
s, and a final extension at 72 °C for 5 min. The SNPs were
genotyped by PCR-restriction fragment length polymorphism
(RFLP) analysis. PCR products of rs11209032, rs17375018,
and  rs7517847  polymorphisms  were  respectively  digested
with  4  U  of  XspI  (TaKaRa,  Dalian,  China),  BsurI  (New
England Biolabs, Inc., Ontario, Canada), and Ec0147I (New
England Biolabs, Inc, Ontario, Canada) restriction enzymes
(Table 2) in a 10 μl reaction volume overnight. Digestion
products were visualized on a 3.5% agarose gel and stained
with GoldView™ (SBS Genetech, Beijing, China). Direct
sequencing  was  also  preformed  by  the  Invitrogen
Biotechnology Company (Shanghai, China) using randomly
selected subjects (20% of all samples) to validate the method
used in this study.
Statistical  analysis:  The  Hardy–Weinberg  equilibrium
(HWE) was tested using the χ2 test. We compared the patterns
of linkage disequilibrium (LD) of SNPs with the international
HapMap subjects using Haploview 4.0. Genotype frequencies
were  estimated  by  direct  counting.  Allele  and  genotype
frequencies were compared between patients and controls by
the χ2 test using SPSS (version 10.0; SPSS Inc., Chicago, IL).
The  p  values  were  corrected  (pc)  using  the  Bonferroni
correction by multiplying the p value with the number of
analyses performed. A pc<0.05 was considered significant.
RESULTS
The Fuchs’ syndrome cohort consisted of 138 consecutive
subjects which all belonged to the Chinese Han population (71
males and 67 females). The average age of the patients with
Fuchs’ syndrome in the study was 37.4±12.4 years (range: 16
to 57 years). The healthy controls included 407 subjects (221
males and 186 females), with an average age of 38.4±12.0
years (range: 24 to 63 years). The age and gender distribution
of the patients with Fuchs’ syndrome and controls are shown
in Table 1.
The three SNPs of IL23R (rs11209032, rs17375018, and
rs7517847) were successfully genotyped in 138 patients with
Fuchs’  syndrome  and  407  healthy  controls.  The  results
showed that the distribution of the genotypes and alleles did
not deviate from the Hardy–Weinberg equilibrium (HWE).
The distribution of both genotypic and allelic frequencies of
the three tested IL23R polymorphisms is shown in Table 3.
The results showed that the frequency of the rs11209032 AA
genotype was significantly increased in patients with Fuchs’
syndrome  as  compared  to  controls  (pc=0.036,  OR  1.86,
95%CI 1.21 to 2.86). An increased frequency of the A allele
of rs11209032 was also observed in patients with Fuchs’
TABLE 1. THE AGE AND GENDER DISTRIBUTION OF PATIENTS WITH FUCHS’ SYNDROME AND CONTROLS.
  Patients with Fuchs’ syndrome Healthy controls
Clinical features Total (n=120) % Total (n=407) %
Age at onset (years±S.D) 37.4±12.3   38.4±12.0  
Range 16–57   24–63  
Sex
Male 61 50.8 221 54.2
Female 59 49.2 186 45.8
TABLE 2. PRIMERS OF IL23R SNPS AND RESTRICTION ENZYMES USED FOR RFLP ANALYSIS.
SNP Primers Restriction enzyme
rs7517847 5′-CCTTTCACCTATTCCCAAGGCC-3′ ECO147I
  5′-GGGCCTAGGAGACAGCCCATAA-3′  
rs11209032 5′-CTCCCTACATCACCCTCTTTGCACT-3′ XSPI
  5′-TGATAAGGCAATCCGGTGGTTC-3′  
rs17375018 5′-TTTTTCCCATCTTCTTTCTTAA-3′ BSURI
  5′-CGCCCAGCCCTCTTCTCTAATT-3′  
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46.7%, p=0.009, OR 1.44, 95%CI 1.10–1.90). However, there
was  no  difference  when  the  Bonferroni  correction  was
performed  (pc=0.054,  n=6).  There  was  no  difference
concerning the genotype and allele of both rs7517847 and
rs1737508 SNPs between the patients with Fuchs’ syndrome
and  the  controls.  Haplotype  analysis  using  Haploview
software showed no difference between patients with Fuchs’
syndrome and controls. Stratification analysis according to
gender did not show an influence of sex on the association of
IL23R with this syndrome.
DISCUSSION
The  present  study  was  performed  to  investigate  the
association of IL23R polymorphisms with Fuchs’ syndrome
in a Chinese Han population. The results showed that the AA
genotype  of  the  rs11209032  SNP  was  associated  with  an
increased susceptibility to Fuchs’ syndrome. However, there
was no difference with regard to the genotypes and alleles of
rs7517847  and  rs17375018  between  patients  with  Fuchs’
syndrome and normal controls.
Fuchs’ syndrome is a relatively rare uveitis entity [2].
Although the etiology and pathogenesis of Fuchs’ syndrome
are  not  fully  understood,  several  hypotheses  including
sympathetic lesions, association with ocular toxoplasmosis,
vascular  abnormalities,  viral  infections  and  autoimmunity
have been proposed [15,16]. Among these presumptions, a
viral  infection  has  been  accepted,  as  supported  by  the
demonstration  of  local  intraocular  antiviral  antibody
production [16-18],Elevatedγ-interferon and interleukin 10,
an increased number of CD8+ T cells in the aqueous humor
and a positive cellular response to retinal S antigen have been
reported in patients with Fuchs’ syndrome [19-22]. Several
inflammatory diseases have been reported to have genetic
background. However, the genetic susceptibility of Fuchs’
syndrome has scarcely been investigated principally due to a
lack of sufficient samples from these patients. One hundred
and  thirty-eight  samples,  consecutively  collected  from
Chinese Han patients with Fuchs’ syndrome during the past
five  years,  made  it  possible  to  analyze  the  association  of
polymorphisms of a candidate gene with this disease.
Several strategies can be followed to select a candidate
gene in the study of genetic susceptibility to certain diseases.
These include the identification of a candidate gene based on
Genome-wide  association  study  results  or  by  chosing  a
susceptibility gene already identified in other related diseases.
Alternatively one can chose to study a gene according to its
relevant functions that might be functional in the pathogenesis
of the disease of interest. In this study, we selected the IL23
receptor (IL23R) as a candidate gene principally based on the
fact that the interaction of IL23R with its ligand IL23 results
in  an  increase  of  signal  transducers  and  activators  of
transcription signaling which can consequently promote the
production  of  IL17,  a  potent  pro-inflammatory  cytokine
already  identified  to  be  involved  in  various  chronic
inflammatory diseases [23]. It has been suggested that an
upregulated production of IL23R which is associated with
certain SNP alleles in its gene could confer risk for the disease
[24]. The association of IL23R polymorphisms with several
chronic inflammatory diseases or autoinflammatory diseases
[11-13,25] also stimulated us to investigate its association
with Fuchs’ syndrome in the Chinese Han population. As
TABLE 3. FREQUENCIES OF ALLELES AND GENOTYPES OF IL23R POLYMORPHISMS IN PATIENTS WITH FUCHS’ SYNDROME AND CONTROLS.
SNP Genotype
allele
FHC (n=138) Controls
(n=407) χ2 p value pc OR (95% CI)
rs17375018 AA 9(6.5%) 38(9.3%) 1..36 0.309 NS 0.68 (0.32–1.44)
  AG 62(44.9%) 192(47.2%) 0.209 0.647 NS 0.91(0.62–1.35)
  GG 67(48.6%) 177(43.5%) 1.068 0.301 NS 1.23(0.83–1.81)
  A 80(28.9%) 268(32.9%) 1.471 0.225 NS 0.83(0.62–1.12)
  G 196(71.1%) 546(67.1%) 1.471 0.225 NS 1.20(0.89–1.62)
rs7517847 TT 52(37.7%) 134(32.9%) 1.038 0.308 NS 1.23(0.82–1.84)
  GT 56(40.6%) 198(48.7%) 2.696 0.101 NS 0.72(0.49–1.06)
  GG 30(21.7%) 75(18.4%) 0.727 0.394 NS 1.23(0.76–1.98)
  G 116(42.0%) 348(42.8%) 0.044 0.834 NS 0.97(0.74–1.28)
  T 160(58.0%) 466(57.2%) 0.044 0.834 NS 1.03 (0.78–1.36)
rs11209032 GG 29(20.2%) 111(27.3%) 2.114 0.146 NS 0.71(0.45–1.13)
  AG 64(47.2%) 212(52.1%) 1.345 0.246 NS 0.80(0.54–1.17)
  AA 45(32.6%) 84(20.6%) 8.173 0.004 0.036 1.86(1.21–2.86)
  A 154(56.2%) 380(46.7%) 6.851 0.009 NS 1.44(1.10–1.90)
  G 122(43.8%) 434(53.3%) 6.851 0.009 NS 0.69(0.53–0.91)
       In  the  Table,  FHC=Fuchs  heterochromic  cyclitis;  OR=odds  ratio;  NS=not  significant.  95%CI=95%  confidence  interval;
       pc=corrected p.
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following measures were used to validate the results. The
healthy  controls  and  patients  within  the  Chinese  Han
population were strictly age-, sex-, and ethnically matched.
Sequencing of the PCR products was performed in 10% of the
tested samples to validate the PCR-RFLP data.
Since there are numerous SNPs in a candidate gene and
because only a few SNPs may be relevant in the pathogenesis
of disease, it is extremely important to select the relevant
SNPs. In this study, we chose rs7517847, rs11209032, and
rs17375018 as the tested SNPs are mainly based on earlier
studies [10,11,26-28]. The SNPs rs11209032 and rs7517847
were  previously  found  to  be  associated  with  diseases  in
different  ethnic  populations  [11,26,28].  Therefore,  we
selected them as candidate SNPs. Our results showed that the
AA genotype of rs11209032 was positively associated with
Fuchs’ syndrome in the Chinese Han population. This result
is consistent with earlier findings reported in Crohn’s disease
in a German population and in Behcet’s disease in a Chinese
Han  population  [10,25].  We  were  not  able  to  detect  an
association between rs7517847 and Fuchs’ syndrome, a result
which  is  in  agreement  with  earlier  findings  reported  in
Crohn’s disease in Japan [28]. The third SNP tested in this
study  was  rs17375018,  which  we  recently  identified  as  a
susceptibility factor for Behcet’s disease [10]. We did not find
an association of this latter SNP with Fuchs’ syndrome, which
is consistent with earlier findings observed in VKH syndrome,
anautoimmune uveitis entity commonly seen in China [29].
Taken together, these results suggest that Fuchs’ syndrome
may have a different genetic background as compared to other
uveitis entities.
Like  other  candidate  gene  studies,  there  are  several
limitations  in  our  study.  As  the  power  to  detect  disease
susceptibility  genes  is  influenced  by  the  number  of  the
patient’s samples, the size of patient samples in our study
seemed  to  be  relatively  small  and  the  patients  were  only
recruited  from  the  Chinese  Han  population.  The  results
observed in this study need to be confirmed using large sample
sizes and in other ethnic populations. Furthermore, it is not
clear how the associated SNP, rs11209032, as identified in the
present  study,  exerts  its  influence  on  the  pathogenesis  of
Fuchs’ syndrome. More studies are needed to address this
issue.
In summary, our study showed that the rs11209032 AA
genotype  of  the  IL23R  gene  is  positively  associated  with
Fuchs’ syndrome in the Chinese Han population. We did not
find an association between the other two tested SNPs of
IL23R, rs7517847 and rs17375018 and Fuchs’ syndrome in
this population.
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